Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Enalapril 7.5mg/5ml oral liquid
0205051I0AABWBW
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 7mg/5ml oral liquid
0205051I0AABCBC
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enalapril 8mg/5ml oral liquid
0205051I0AABQBQ
|
Enalapril maleate | Enalapril maleate | Cardiovascular System | No data available |
|
Enebium 10mg orodispersible tablets
0212000AABCABAN
|
Enebium | Rosuvastatin calcium | Cardiovascular System | No data available |
|
Enebium 5mg orodispersible tablets
0212000AABCAAAM
|
Enebium | Rosuvastatin calcium | Cardiovascular System | No data available |
|
Enoximone 100mg/20ml solution for injection ampoules
0201020G0AAAAAA
|
Enoximone | Enoximone | Cardiovascular System | No data available |
|
Enprin 75mg gastro-resistant tablets
0209000A0BKAAAK
|
Enprin | Aspirin | Cardiovascular System | No data available |
|
Ephedrine 30mg/10ml inj pre-filled syringes
0207020Z0AAACAC
|
Ephedrine hydrochloride (Parenteral) | Ephedrine hydrochloride | Cardiovascular System | No data available |
|
Ephedrine 30mg/10ml solution for injection ampoules
0207020Z0AAADAD
|
Ephedrine hydrochloride (Parenteral) | Ephedrine hydrochloride | Cardiovascular System | No data available |
|
Ephedrine 30mg/1ml solution for injection ampoules
0207020Z0AAAAAA
|
Ephedrine hydrochloride (Parenteral) | Ephedrine hydrochloride | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg (pH10.5) inf vials
0208010E0AAABAB
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr & solv inf vials
0208010E0AAAEAE
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr for soln (pH12) inf vials
0208010E0AAADAD
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram (pH10.5) inf vials
0208010E0AAAAAA
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr & solv inf vials
0208010E0AAAFAF
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr for soln (pH12) inf vials
0208010E0AAACAC
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Eprosartan 300mg/5ml oral liquid
0205052W0AAADAD
|
Eprosartan | Eprosartan | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 120,000unit inj vials
0211000Z0AAABAB
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj pfs
0211000Z0AAAHAH
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj vials
0211000Z0AAADAD
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 240,000unit inj vials
0211000Z0AAACAC
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj pfs
0211000Z0AAAIAI
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj vials
0211000Z0AAAEAE
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj pfs
0211000Z0AAAJAJ
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj vials
0211000Z0AAAFAF
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.